154 related articles for article (PubMed ID: 32042831)
1. In silico analysis for determining the deleterious nonsynonymous single nucleotide polymorphisms of
Yadegari F; Majidzadeh K
Mol Biol Res Commun; 2019 Dec; 8(4):141-150. PubMed ID: 32042831
[TBL] [Abstract][Full Text] [Related]
2. Evolution- and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2).
George DC; Chakraborty C; Haneef SA; Nagasundaram N; Chen L; Zhu H
Theranostics; 2014; 4(4):366-85. PubMed ID: 24578721
[TBL] [Abstract][Full Text] [Related]
3. BRCA2 Polymorphisms and Breast Cancer Susceptibility: a Multi-Tools Bioinformatics Approach.
Jan H; Khan NU; Al-Qaaneh AM; Tasleem M; Almutairi MH; Ali I
Cell Physiol Biochem; 2024 Mar; 58(2):128-143. PubMed ID: 38623065
[TBL] [Abstract][Full Text] [Related]
4. Determination of deleterious single-nucleotide polymorphisms of human LYZ C gene: an in silico study.
Venkata Subbiah H; Ramesh Babu P; Subbiah U
J Genet Eng Biotechnol; 2022 Jul; 20(1):92. PubMed ID: 35776277
[TBL] [Abstract][Full Text] [Related]
5. Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
Ernst C; Hahnen E; Engel C; Nothnagel M; Weber J; Schmutzler RK; Hauke J
BMC Med Genomics; 2018 Mar; 11(1):35. PubMed ID: 29580235
[TBL] [Abstract][Full Text] [Related]
6. Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact.
Badgujar NV; Tarapara BV; Shah FD
PLoS One; 2019; 14(8):e0220711. PubMed ID: 31398194
[TBL] [Abstract][Full Text] [Related]
7. Predicting the Most Deleterious Missense Nonsynonymous Single-Nucleotide Polymorphisms of Hennekam Syndrome-Causing CCBE1 Gene, In Silico Analysis.
Shinwari K; Guojun L; Deryabina SS; Bolkov MA; Tuzankina IA; Chereshnev VA
ScientificWorldJournal; 2021; 2021():6642626. PubMed ID: 34234628
[TBL] [Abstract][Full Text] [Related]
8. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
Doss CG; Nagasundaram N
Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
[TBL] [Abstract][Full Text] [Related]
9. Computational analysis of structural and functional evaluation of the deleterious missense variants in the human
Bouqdayr M; Abbad A; Baba H; Saih A; Wakrim L; Kettani A
J Biomol Struct Dyn; 2023; 41(23):14179-14196. PubMed ID: 36764830
[TBL] [Abstract][Full Text] [Related]
10. Prediction of potential deleterious nonsynonymous single nucleotide polymorphisms of HIF1A gene: A computational approach.
Jamali Z; Taheri-Anganeh M; Entezam M
Comput Biol Chem; 2020 Oct; 88():107354. PubMed ID: 32801061
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Significance of Unknown Sequence Variants in BRCA Genes.
Calò V; Bruno L; La Paglia L; Perez M; Margarese N; Di Gaudio F; Russo A
Cancers (Basel); 2010 Sep; 2(3):1644-60. PubMed ID: 24281179
[TBL] [Abstract][Full Text] [Related]
12. Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.
Spearman AD; Sweet K; Zhou XP; McLennan J; Couch FJ; Toland AE
J Clin Oncol; 2008 Nov; 26(33):5393-400. PubMed ID: 18824701
[TBL] [Abstract][Full Text] [Related]
13. Impacts of Nonsynonymous Single Nucleotide Polymorphisms of Adiponectin Receptor 1 Gene on Corresponding Protein Stability: A Computational Approach.
Saleh MA; Solayman M; Paul S; Saha M; Khalil MI; Gan SH
Biomed Res Int; 2016; 2016():9142190. PubMed ID: 27294143
[TBL] [Abstract][Full Text] [Related]
14. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
[TBL] [Abstract][Full Text] [Related]
15. Computational analysis for the determination of deleterious nsSNPs in human MTHFR gene.
Desai M; Chauhan JB
Comput Biol Chem; 2018 Jun; 74():20-30. PubMed ID: 29524840
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Structural and Functional Effects of Nonsynonymous SNPs in the Human Serotonin Transporter Gene Through
Mia MA; Uddin MN; Akter Y; Jesmin ; Wal Marzan L
Bioinform Biol Insights; 2022; 16():11779322221104308. PubMed ID: 35706533
[TBL] [Abstract][Full Text] [Related]
17. BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history.
Bisgin A; Boga I; Yalav O; Sonmezler O; Tug Bozdogan S
Breast J; 2019 Sep; 25(5):1029-1033. PubMed ID: 31228304
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.
Guidugli L; Shimelis H; Masica DL; Pankratz VS; Lipton GB; Singh N; Hu C; Monteiro ANA; Lindor NM; Goldgar DE; Karchin R; Iversen ES; Couch FJ
Am J Hum Genet; 2018 Feb; 102(2):233-248. PubMed ID: 29394989
[TBL] [Abstract][Full Text] [Related]
19. Predicting the functional and structural consequences of nsSNPs in human methionine synthase gene using computational tools.
Desai M; Chauhan JB
Syst Biol Reprod Med; 2019 Aug; 65(4):288-300. PubMed ID: 30676783
[TBL] [Abstract][Full Text] [Related]
20. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
